Moreover, high TGF-β expression in tumor samples was associated with worse overall survival (OS) and relapse-free survival (RFS), supporting its potential role as a prognostic marker in GC progression (Figure 1b,c). The gene discussed is TGFB1; the disease is neoplasm.